Data as of Jan 30
| +0.09 / +1.10%|
The 1 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 11.50, with a high estimate of 11.50 and a low estimate of 11.50. The median estimate represents a +38.55% increase from the last price of 8.30.
The current consensus among 1 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.